Board of Directors
Guiding the Mission. Shaping the Future of Precision Medicine.
Board
Certified Standard
MD
Physician-Led
100%
Patient-Centered
ABOPM
Setting the Standard
The Board of Directors of the American Board of Precision Medicine (ABOPM) provides strategic leadership, governance, and vision for the organization’s mission to transform healthcare through precision medicine.
Comprised of distinguished physicians, scientists, and leaders across medicine, research, technology, and healthcare innovation, the Board brings together diverse expertise to guide the advancement of personalized, data-driven medicine. Their leadership ensures that ABOPM remains at the forefront of developing standards, education, and certification pathways that prepare physicians for the next era of healthcare.
Through strategic oversight and collaboration, the Board of Directors helps advance the organization’s commitment to bridging the gap between scientific discovery and real-world clinical application of precision medicine.
Meet the Board
Distinguished leaders who guide the American Board of Precision Medicine's mission to advance personalized, data-driven healthcare and establish rigorous standards for physician education and certification.
Anil Bajnath,
MD, MBA
"Advancing a new paradigm of medicine - where root-cause diagnostics, individualized treatment, and proactive health optimization define the standard of care."
Dr. Anil Bajnath is a physician leader, educator, and innovator in the field of precision medicine. As the Founder and CEO of the American Board of Precision Medicine (ABOPM), he provides strategic vision and leadership for the organization's mission to establish rigorous standards for physician education and certification in personalized, data-driven healthcare.
Dr. Bajnath serves as Adjunct Faculty at George Washington University School of Medicine, directing courses in clinical genomics, proteomics, and metabolomics - bridging the gap between cutting-edge omics science and everyday clinical practice.
He earned his medical degree from Ross University School of Medicine and completed his Family Medicine residency at the University of Maryland. He holds an additional MBA in Healthcare Services.
Board-certified in Family Medicine and Regenerative Medicine, Dr. Bajnath holds additional training in Functional Medicine, Anti-Aging Medicine, clinical nutrition, medical acupuncture, and European Biological Medicine.
As founder of the Institute for Human Optimization (IFHO) in Maryland, Dr. Bajnath leads a clinical practice at the frontier of next-generation personalized healthcare - integrating genomics, advanced biomarker analysis, microbiome science, and biometric lifestyle monitoring to identify root causes of complex and chronic disease.
Institute for Human Optimization
Founded by Dr. Bajnath, IFHO is a Maryland-based clinical practice delivering next-generation personalized healthcare - integrating advanced diagnostics with individualized, root-cause medicine.
Setting the Standard for Individualized Medicine
At IFHO, Dr. Bajnath integrates genomics, advanced biomarker analysis, microbiome science, and biometric lifestyle monitoring to build a complete physiological portrait of each patient - identifying root causes of complex and chronic disease with unprecedented precision.
IFHO operates at the intersection of clinical excellence and cutting-edge science, offering a level of individualized care that goes far beyond conventional medicine. Every protocol is uniquely tailored to the patient's genetic, biochemical, and lifestyle profile.
Learn About IFHOGenomics & Omics Integration
Clinical genomics, proteomics, and metabolomics interpreted in the context of each patient's full health picture.
Advanced Biomarker Analysis
In-depth diagnostic profiling including microbiome science and biometric lifestyle monitoring to reveal hidden drivers of disease.
Proactive Health Optimization
Moving beyond reactive care to individualized strategies that preserve long-term vitality, resilience, and peak performance.
Meet the Board
Distinguished leaders who guide the American Board of Precision Medicine's mission to advance personalized, data-driven healthcare and establish rigorous standards for physician education and certification.
Eric Van Gieson,
PhD
"Bridging biomedical science and national security — translating cutting-edge epigenetics and multiomics into real-world solutions that protect and optimize human health."
Dr. Eric Van Gieson is a biotech and medtech leader with more than 25 years of experience across industry, academia, and government. He is currently CEO of EPOCH Epigenetics and consults on building partnerships between government and industry to transition biomedical technologies to end users.
His leadership roles have included CTO at NSRI, Director of Biosurveillance and Diagnostics at MRIGlobal, Chief of the Diagnostics, Disease Surveillance, and Threat Detection Division at DTRA, and Principal Professional Staff at Johns Hopkins APL.
At DARPA, Dr. Van Gieson launched programs using host-based epigenetics and multiomic methods to mitigate emerging diseases, optimize human performance, and create next-generation diagnostics — efforts that helped catalyze more than $100 million in commercial and private investment.
He earned his PhD in Biomedical Engineering and BS in Chemical Engineering from the University of Virginia. Outside of his professional work, Dr. Van Gieson enjoys family time, old cars, wing foiling, mountain biking, and snowboarding.
Leadership
With Purpose
The Board of Directors plays a critical role in shaping the strategic direction and long-term vision of the American Board of Precision Medicine (ABOPM).
Through their leadership, the Board ensures the organization continues advancing innovation, education, and global collaboration in precision medicine - holding the standard that defines the field.
The Board supports the mission of ABOPM by helping to:
Why Board Leadership Matters
The standard of precision medicine is set at the top - by those with the expertise and vision to lead it.
A credentialed, expert-led board ensures ABOPM's certifications carry the weight and legitimacy the field demands.
Board members bring international perspectives across academia, government, and industry to shape a truly global precision medicine standard.
The Board champions the needs of precision medicine practitioners - ensuring certification pathways reflect real clinical demands.
Every standard, curriculum, and certification is grounded in the latest evidence - guided by board members at the frontier of biomedical science.
The Role of Multi-Omics in
Precision Medicine
Disease is not driven by a single gene or molecule — it emerges from the complex interplay of biological systems. Multi-omics science integrates six distinct layers of molecular data to reveal the full architecture of health and disease, equipping physicians to act with unprecedented precision, speed, and certainty.
The study of DNA sequence, genetic variants, and inherited traits that determine individual disease risk and drug response. Genomics is the foundation upon which all precision medicine is built — revealing the molecular blueprint of every patient.
Explore GenomicsAnalysis of the complete set of RNA transcripts produced by the genome — capturing which genes are actively expressed at any given moment. Transcriptomics is the live readout of cellular activity, bridging genetic sequence and protein production in real time.
Explore TranscriptomicsInvestigation of the entire complement of proteins expressed by a cell or organism — their structures, functions, modifications, and interactions. Proteins are the molecular machines that execute every biological function and constitute the primary targets of most therapeutic drugs.
Explore ProteomicsSystematic measurement of the small molecules — metabolites — produced during cellular metabolism. Metabolomics delivers a real-time biochemical snapshot of cellular function, capturing the downstream effects of genetic variation, environmental exposures, diet, and disease states simultaneously.
Explore MetabolomicsCharacterization of the trillions of microorganisms — bacteria, fungi, and viruses — colonizing the human body. The gut microbiome profoundly influences immunity, metabolism, neurological function, and drug efficacy, making it an essential layer in any complete precision medicine framework.
Explore MicrobiomicsNo single layer is sufficient. Disease is a systems-level phenomenon — genomic variants are expressed through transcriptomics, translated into proteins, reflected in metabolites, and modulated by the microbiome. Clinicians who operate on one layer alone are practicing with an incomplete picture.
Medicine
Paradigm
ABOPM trains and certifies physicians in multi-omics science — providing the interdisciplinary frameworks, clinical standards, and leadership skills to practice precision medicine at the molecular frontier of every specialty.
A Commitment to Excellence
The Board of Directors is committed to upholding the highest standards of scientific integrity, clinical excellence, and professional leadership.
Together, they work to ensure that ABOPM continues to:
- Advance physician training in precision medicine
- Support the development of innovative diagnostic and therapeutic approaches
- Promote ethical and responsible implementation of emerging medical technologies
- Improve patient outcomes through individualized healthcare strategies
Their collective experience and leadership strengthen ABOPM's role as a driving force in the global precision medicine movement.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Why Diversity in Genomic Research Matters for Precision Medicine
Genomic diversity is essential for accurate, equitable precision medicine. Expanding representation in research improves risk prediction, variant interpretation, and ensures better outcomes for all po... ...more
Population Precision
April 23, 2026•8 min read
Multi-Omics Medicine: The Next Evolution of Precision Healthcare
Multi-omics medicine integrates genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive view of disease biology. By analyzing multiple molecular layers together, it enables ... ...more
On the Frontier
April 15, 2026•8 min read
How Biomarker-Guided Medicine Is Changing Everyday Clinical Care
Advances in biomedical research have significantly expanded the role of molecular and physiological indicators in clinical decision-making. Among the most influential of these developments is the incr... ...more
Precision Medicine in Action
April 08, 2026•8 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.